跳至主要内容
临床试验/NL-OMON50389
NL-OMON50389已完成不适用

A feasibility study investigating the safety, performance and gastrointestinal transit of the DV3395 device concept in healthy participants. - DV3395 device concept feasibility study.

ovo Nordisk0 个研究点目标入组 65 人开始时间: 待定最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
65

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 64(—)

入选标准

  • 1.Informed consent obtained before any study-related activities. Study-related
  • activities are any procedures that are carried out as part of the study,
  • including activities to determine suitability for the study.
  • 2. Male or female.
  • 3. Aged 18-55 years (both inclusive) at the time of signing informed consent.
  • 4. Considered to be generally healthy based on the medical history, physical
  • examination, and the results of vital signs, electrocardiogram and clinical
  • laboratory tests performed during the screening visit, as judged by the
  • investigator.
  • 5. Body mass index between 18.5 and 29.9 kg/m2 (both inclusive).

排除标准

  • 1. Any disorder, which in the investigator*s opinion might jeopardise
  • participant*s safety or compliance with the protocol.
  • 2. Presence of any known or suspected clinically significant GI disease or GI
  • disorder (including functional and structural disorders) as judged by the
  • investigator.
  • 3. Presence of diarrhoea, defined as passage of three or more loose or liquid
  • stools per day (or more frequent passage than is normal for the individual)
  • within 14 days prior to screening or between screening and V2
  • pre-administration.
  • 4. Presence of constipation (defined as having < 3 bowel movements per week,
  • hard stools, or any other stool-related issues according to ROME IV criteria
  • for functional constipation) within 14 days prior to screening or between
  • screening and V2 pre-administration.
  • 5. History of clinically significant gastrointestinal or abdominal surgery
  • (including gynaecological/obstetrical and urological procedures) as judged by
  • the investigator.
  • Further criteria apply. See protocol.

研究者

发起方
ovo Nordisk

相似试验

A feasibility study investigating the safety,... | 临床试验